Skip to main content

Table 1 Baseline characteristics of the patients (mean ± SD, for non-parametric values: median, inter-quartile range) p compared to normal.

From: Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure

  All patients (n= 137) Normal (n= 42) Diastolic dysfunction (n = 43) Systolic dysfunction (n = 52) p (compared to normal)
Male sex (%) 88 (65) 23 (55) 23 (54) 43 (83) 1.00/0.0059
Age [y] 53.8 (± 18.1) 37.8 (± 15.9) 62.7 (± 12.5) 59.5 (± 15.2) < 0.0001/< 0.0001
BMI [kg/m2] 25.54 (± 4.36) 23.8 (± 3.4) 26.5 (± 3.8) 26.2 (± 5.1) 0.011/0.018
NT-proBNP [pg/ml] 2378 ± 6253, (median 222 (± 1220) 275.9 ± 519.9 (median 66.8, ± 185.3) 255.9 ± 137.4(median 137, ± 256.7) 5832 ± 9185(median 1583, ± 5109) 0.36/<0.0001
Creatinine clearance [ml/min] 87.48 (± 37.89) 107.9 (± 28.6) 82.1 (± 35.0) 78.5 (± 41.3) 0.003/0.0002
Heart rate [/s] 71.6 (± 13.6) 68.3 (± 13.9) 73.1 (± 13.1) 73.5 (± 13.5) 0.68/0.17
Systolic RR [mmHg] 123.0 123.0 136.8 115.4 0.01/0.19
Diastolic RR [mmHg] 74.0 75.4 80.0 71.2 0.21/0.23
coronary artery disease (%) 41 (30) 1 (2) 10 (23) 28 (54) 0.0077/0.001
previous myocardial infarction (%) 28 (20) 0 5 (12) 21 (40) 0.06/0.0001
arterial hypertension (%) 63 (46) 11 (26) 27 (63) 25 (48) 0.0008/0.049
diabetes mellitus (%) 25 (18) 3 (7) 3 (7) 18 (35) 1.00/0.0046
Hyperlipidemia (%) 40 (29) 2 (5) 15 (35) 22 (42) 0.0018/< 0.0001
Smoker (%) 27 (20) 10 (24) 9 (21) 9 (17) 0.8035
ischemic cardiomyopathy (%) 30 (22) 0 0 29 (56) < 0.0001